Viveka Roychowdhury, Author at Express Pharma - Page 7 of 36

Can IPRs be part of the COVID-19 solution, rather than the problem?

GenNext at SIRO Clinpharm

Putting the vulnerable first could end the pandemic faster

The politics of pandemics

DPX-COVID-19 has potential to improve duration of immune response

The back-to-AYUSH wave

Navigating a COVIDitised world

Surfing the digital wave in pharma retail

Agilent supports customer laboratories at every step: Sandeep Tandon

Our digital-funding-network will support India pharma’s next phase of super-growth